Nifty

:

24774.30

Sensex

:

78639.03

390.70 (1.60%)
544.39 (0.70%)

Login

Nifty
Sensex

:
:

24774.30
78639.03

390.70 (1.60%)
544.39 (0.70%)

Medplus Health Services Ltd.

Retailing

Rating :

51/99

BSE: 543427 | NSE: MEDPLUS

Watchlist

NSE BSE

696.40

03-Aug-2026

Open
High
Low
Previous Close

704.95
708.75
695
704.95

Volume
Traded Value (lacs)
52 Week High
52 Week Low

218379
152661269.85
1022.2
653

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,363.94
39.74
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,901.78
N/A
4.18

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.11
12.77
7.01

EBITDA CAGR (%)

10 Years
5 Years
3 Years

23.35
16.67
10.96

PAT CAGR (%)

10 Years
5 Years
3 Years

22.51
18.05
49.70

P:E (Median)

8 Years
5 Years
3 Years

-
105.33
84.00

P:BV (Average)

8 Years
5 Years
3 Years

-
6.24
5.55

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
24.90
19.41

Earnings Forecasts:

(Updated: 01-08-2026)

Description 2026 2027 2028 2029
Adj EPS 75 -18 21.88 17.37
P/E Ratio 9.29 -38.69 31.83 40.09
Revenue 39.14 31.66 23.86 6840.63
EBITDA 7947.54 9102.91 10645 594.71
Net Income 713.21 843.29 1022.38 205.46
ROA 250.01 309.11 410.25 6.32
P/B Ratio -1.00 -0.78 -0.60 4.27
ROE 4.41 3.86 - 10.42
FCFF 11.81 13 13.9 283.76
FCFF Yield 336.05 404.76 360.32 2.63
Net Debt 3.12 3.76 3.34 -558.5
BVPS -696.68 -889.95 -1164.5 163.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 222.64 183.88 21.08% 248.04 201.75 22.94% 223.00 176.79 26.14% 205.65 156.23 31.63%
Expenses 193.71 159.97 21.09% 220.63 177.90 24.02% 194.28 158.10 22.88% 178.57 139.28 28.21%
EBITDA 28.93 23.91 21.00% 27.40 23.85 14.88% 28.72 18.69 53.67% 27.08 16.94 59.86%
EBIDTM 13.00% 13.00% 11.05% 11.82% 12.88% 10.57% 13.17% 10.85%
Other Income 3.27 2.65 23.40% 2.49 2.65 -6.04% 2.70 2.19 23.29% 2.94 2.25 30.67%
Interest 2.22 2.15 3.26% 1.40 2.08 -32.69% 2.40 2.35 2.13% 2.37 2.09 13.40%
Depreciation 6.96 6.72 3.57% 5.44 6.51 -16.44% 7.19 6.50 10.62% 7.04 7.47 -5.76%
PBT 23.02 17.68 30.20% 23.06 17.91 28.75% 21.83 12.03 81.46% 20.61 9.64 113.80%
Tax 5.57 4.15 34.22% 6.38 3.93 62.34% 5.25 2.66 97.37% 4.98 1.89 163.49%
PAT 17.45 13.53 28.97% 16.67 13.98 19.24% 16.58 9.37 76.95% 15.63 7.75 101.68%
PATM 7.84% 7.36% 6.72% 6.93% 7.43% 5.30% 7.60% 4.96%
EPS 1.45 1.13 28.32% 1.39 1.16 19.83% 1.38 0.78 76.92% 1.30 0.65 100.00%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 1,879.60 1,542.63 21.84% 1,864.38 1,509.61 23.50% 1,806.12 1,561.45 15.67% 1,679.33 1,576.17 6.54%
Expenses 1,746.36 1,411.90 23.69% 1,695.21 1,373.24 23.45% 1,647.50 1,428.92 15.30% 1,530.48 1,451.73 5.42%
EBITDA 133.24 130.73 1.92% 169.17 136.37 24.05% 158.62 132.52 19.70% 148.85 124.44 19.62%
EBIDTM 7.09% 8.47% 9.07% 9.03% 8.78% 8.49% 8.86% 7.89%
Other Income 19.83 15.02 32.02% 20.59 15.79 30.40% 18.24 12.52 45.69% 17.47 11.60 50.60%
Interest 33.27 27.36 21.60% 33.48 26.84 24.74% 30.83 25.97 18.71% 28.82 25.12 14.73%
Depreciation 77.92 65.62 18.74% 75.95 64.21 18.28% 72.74 62.47 16.44% 68.56 63.14 8.58%
PBT 41.88 52.77 -20.64% 80.34 61.12 31.45% 73.29 56.60 29.49% 68.94 47.78 44.29%
Tax 8.71 10.42 -16.41% 16.37 9.80 67.04% 15.50 10.73 44.45% 13.43 9.08 47.91%
PAT 33.17 42.34 -21.66% 63.97 51.32 24.65% 57.79 45.87 25.99% 55.50 38.70 43.41%
PATM 1.76% 2.74% 3.43% 3.40% 3.20% 2.94% 3.31% 2.46%
EPS 2.76 3.54 -22.03% 5.33 4.29 24.24% 4.82 3.83 25.85% 4.63 3.24 42.90%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 899.33 860.57 713.10 467.03 213.93 145.71 68.31 61.11 9.52 9.42 2.16 Net Sales Growth 25.14% 20.68% 52.69% 118.31% 46.82% 113.31% 11.78% 541.91% 1.06% 336.11% Cost Of Goods Sold 683.18 652.35 546.55 351.04 156.87 118.57 50.24 43.53 0.00 0.00 0.00 Gross Profit 216.15 208.22 166.54 116.00 57.05 27.15 18.08 17.59 9.52 9.42 2.16 GP Margin 24.03% 24.20% 23.35% 24.84% 26.67% 18.63% 26.47% 28.78% 100% 100% 100% Total Expenditure 787.19 753.46 635.30 434.85 207.67 142.41 77.11 86.29 12.99 14.29 4.10 Power & Fuel Cost - 5.81 5.31 4.70 2.57 0.57 0.18 0.06 0.06 0.07 0.06 % Of Sales - 0.68% 0.74% 1.01% 1.20% 0.39% 0.26% 0.10% 0.63% 0.74% 2.78% Employee Cost - 54.30 47.22 43.69 28.14 13.73 22.57 6.91 3.76 3.57 1.66 % Of Sales - 6.31% 6.62% 9.35% 13.15% 9.42% 33.04% 11.31% 39.50% 37.90% 76.85% Manufacturing Exp. - 7.70 6.93 5.20 1.45 0.51 0.32 1.69 1.51 1.24 0.86 % Of Sales - 0.89% 0.97% 1.11% 0.68% 0.35% 0.47% 2.77% 15.86% 13.16% 39.81% General & Admin Exp. - 29.09 24.82 20.39 11.34 4.92 3.48 1.70 7.41 9.09 1.09 % Of Sales - 3.38% 3.48% 4.37% 5.30% 3.38% 5.09% 2.78% 77.84% 96.50% 50.46% Selling & Distn. Exp. - 2.35 3.04 7.83 6.28 3.41 0.07 0.00 0.22 0.12 0.03 % Of Sales - 0.27% 0.43% 1.68% 2.94% 2.34% 0.10% 0% 2.31% 1.27% 1.39% Miscellaneous Exp. - 1.87 1.43 2.00 1.00 0.70 0.26 32.41 0.03 0.19 0.03 % Of Sales - 0.22% 0.20% 0.43% 0.47% 0.48% 0.38% 53.04% 0.32% 2.02% 18.06% EBITDA 112.13 107.11 77.80 32.18 6.26 3.30 -8.80 -25.18 -3.47 -4.87 -1.94 EBITDA Margin 12.47% 12.45% 10.91% 6.89% 2.93% 2.26% -12.88% -41.20% -36.45% -51.70% -89.81% Other Income 11.40 10.77 8.94 7.31 23.18 9.54 2.11 1.92 1.03 1.26 0.37 Interest 8.39 8.31 8.63 8.44 6.54 2.63 0.56 0.27 0.00 12.40 0.00 Depreciation 26.63 26.39 26.94 24.11 15.31 4.63 1.31 0.84 0.13 0.16 0.39 PBT 88.52 83.17 51.17 6.94 7.59 5.58 -8.57 -24.36 -2.57 -16.16 -1.95 Tax 22.18 20.76 10.84 -2.50 2.04 0.00 0.00 0.51 0.00 0.00 0.00 Tax Rate 25.06% 24.96% 21.18% -36.02% 26.88% 0.00% 0.00% -2.09% 0.00% 0.00% 0.00% PAT 66.33 62.41 40.34 9.44 5.54 5.58 -8.57 -24.87 -2.57 -16.16 -1.95 PAT before Minority Interest 66.33 62.41 40.34 9.44 5.54 5.58 -8.57 -24.87 -2.57 -16.16 -1.95 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.38% 7.25% 5.66% 2.02% 2.59% 3.83% -12.55% -40.70% -27.00% -171.55% -90.28% PAT Growth 48.62% 54.71% 327.33% 70.40% -0.72% - - - - - EPS 5.52 5.20 3.36 0.79 0.46 0.46 -0.71 -2.07 -0.21 -1.35 -0.16

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 7,229.43 6,892.47 6,136.05 5,624.85 4,557.58 3,779.28 3,069.27 2,870.60 2,272.74 2,131.79 2,011.29 Net Sales Growth 16.79% 12.33% 9.09% 23.42% 20.59% 23.13% 6.92% 26.31% 6.61% 5.99% Cost Of Goods Sold 5,364.16 5,084.61 4,640.66 4,391.63 3,557.69 2,982.37 2,425.24 2,335.88 1,843.70 1,733.77 1,617.23 Gross Profit 1,865.27 1,807.86 1,495.39 1,233.23 999.89 796.90 644.03 534.72 429.04 398.02 394.07 GP Margin 25.80% 26.23% 24.37% 21.92% 21.94% 21.09% 20.98% 18.63% 18.88% 18.67% 19.59% Total Expenditure 6,619.55 6,268.09 5,632.59 5,253.56 4,276.21 3,490.40 2,840.05 2,736.93 2,215.93 2,073.15 1,934.75 Power & Fuel Cost - 55.80 52.74 45.50 31.71 17.78 13.29 13.70 11.98 10.96 10.03 % Of Sales - 0.81% 0.86% 0.81% 0.70% 0.47% 0.43% 0.48% 0.53% 0.51% 0.50% Employee Cost - 884.53 726.02 625.52 545.13 393.92 338.65 272.40 211.37 189.97 182.19 % Of Sales - 12.83% 11.83% 11.12% 11.96% 10.42% 11.03% 9.49% 9.30% 8.91% 9.06% Manufacturing Exp. - 13.49 11.48 9.11 6.19 4.57 2.63 4.57 3.20 2.98 2.68 % Of Sales - 0.20% 0.19% 0.16% 0.14% 0.12% 0.09% 0.16% 0.14% 0.14% 0.13% General & Admin Exp. - 101.91 90.50 76.56 62.06 39.66 28.42 25.37 99.16 88.27 77.80 % Of Sales - 1.48% 1.47% 1.36% 1.36% 1.05% 0.93% 0.88% 4.36% 4.14% 3.87% Selling & Distn. Exp. - 120.78 103.36 98.28 67.76 47.35 29.27 47.58 35.19 36.32 40.61 % Of Sales - 1.75% 1.68% 1.75% 1.49% 1.25% 0.95% 1.66% 1.55% 1.70% 2.02% Miscellaneous Exp. - 6.99 7.82 6.96 5.67 4.75 2.54 37.43 11.33 10.89 40.61 % Of Sales - 0.10% 0.13% 0.12% 0.12% 0.13% 0.08% 1.30% 0.50% 0.51% 0.21% EBITDA 609.88 624.38 503.46 371.29 281.37 288.88 229.22 133.67 56.81 58.64 76.54 EBITDA Margin 8.44% 9.06% 8.20% 6.60% 6.17% 7.64% 7.47% 4.66% 2.50% 2.75% 3.81% Other Income 76.13 71.32 48.62 40.01 46.08 31.36 21.55 17.28 9.83 7.22 8.26 Interest 126.40 137.50 118.95 113.65 98.72 82.94 67.40 46.80 16.13 27.74 25.42 Depreciation 295.17 282.87 249.84 224.21 181.56 119.36 88.27 74.81 13.96 12.47 11.46 PBT 264.45 275.33 183.29 73.44 47.16 117.94 95.10 29.36 36.55 25.64 47.93 Tax 54.01 55.72 33.06 7.87 -2.94 23.23 31.99 27.57 15.65 -16.71 19.09 Tax Rate 20.42% 20.24% 18.04% 10.72% -6.23% 19.70% 33.64% 93.90% 42.82% -65.17% 39.83% PAT 210.43 219.65 150.32 65.48 49.76 95.81 63.86 1.79 20.90 42.35 28.83 PAT before Minority Interest 210.47 219.61 150.23 65.58 50.10 94.72 63.11 1.79 20.90 42.35 28.83 Minority Interest 0.04 0.04 0.09 -0.10 -0.34 1.09 0.75 0.00 0.00 0.00 0.00 PAT Margin 2.91% 3.19% 2.45% 1.16% 1.09% 2.54% 2.08% 0.06% 0.92% 1.99% 1.43% PAT Growth 18.07% 46.12% 129.57% 31.59% -48.06% 50.03% 3,467.60% -91.44% -50.65% 46.90% EPS 17.52 18.29 12.52 5.45 4.14 7.98 5.32 0.15 1.74 3.53 2.40

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,316.11 1,240.35 1,187.65 1,141.28 1,112.78 517.48 395.61 185.21 185.21 100.72 Share Capital 24.01 23.94 23.91 23.86 23.86 0.45 0.19 0.19 0.19 12.40 Total Reserves 1,284.07 1,190.11 1,133.38 1,086.98 1,077.53 468.38 386.72 176.39 179.04 82.59 Non-Current Liabilities 102.54 97.63 82.73 84.69 42.40 7.34 3.96 0.13 0.01 80.83 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 43.03 Long Term Provisions 23.60 12.59 2.99 3.88 0.71 0.88 1.62 0.13 0.01 0.04 Current Liabilities 63.50 68.80 37.43 48.01 32.27 23.60 16.17 6.17 3.34 1.07 Trade Payables 34.03 45.16 17.97 12.79 5.53 2.36 1.11 5.27 2.68 0.69 Other Current Liabilities 25.54 21.32 17.53 34.19 26.01 20.58 14.61 0.63 0.40 0.12 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 3.92 2.31 1.93 1.03 0.74 0.66 0.45 0.27 0.26 0.25 Total Liabilities 1,482.15 1,406.78 1,307.81 1,273.98 1,187.45 548.42 415.74 191.51 188.56 182.62 Net Block 166.92 183.96 191.52 179.41 85.02 22.68 7.17 0.15 0.26 0.37 Gross Block 258.42 251.88 237.83 201.26 92.46 25.91 9.21 1.34 2.03 1.98 Accumulated Depreciation 91.50 67.92 46.32 21.85 7.45 3.23 2.04 1.19 1.77 1.61 Non Current Assets 1,126.99 1,131.50 1,127.31 1,123.40 530.12 441.94 390.84 188.58 183.44 182.05 Capital Work in Progress 1.74 1.23 0.35 17.91 15.52 2.01 0.95 0.00 0.00 0.00 Non Current Investment 930.64 928.23 922.51 917.16 418.45 408.50 381.09 186.03 180.72 177.32 Long Term Loans & Adv. 27.69 15.75 7.93 8.92 11.13 8.75 1.63 2.39 2.47 4.36 Other Non Current Assets 0.00 2.34 5.00 0.00 0.00 0.00 0.00 0.03 0.00 0.01 Current Assets 355.15 275.27 180.50 150.58 657.34 106.48 24.90 2.93 5.11 0.57 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 26.77 18.32 13.96 6.69 3.90 4.79 3.94 0.23 0.14 0.13 Sundry Debtors 132.61 121.62 69.62 37.61 21.29 11.51 8.60 2.08 0.56 0.08 Cash & Bank 139.04 57.02 63.15 90.16 7.44 86.68 10.74 0.53 4.28 0.27 Other Current Assets 56.74 2.74 2.22 1.32 624.71 3.51 1.63 0.09 0.13 0.09 Short Term Loans & Adv. 54.56 75.57 31.56 14.81 603.14 3.10 1.30 0.05 0.11 0.06 Net Current Assets 291.66 206.48 143.07 102.57 625.06 82.88 8.73 -3.24 1.77 -0.49 Total Assets 1,482.14 1,406.77 1,307.81 1,273.98 1,187.46 548.42 415.74 191.51 188.55 182.62

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,975.36 1,740.56 1,577.93 1,491.18 1,417.77 730.55 527.80 325.19 303.47 160.30 Share Capital 24.01 23.94 23.91 23.86 23.86 0.45 0.19 0.19 0.19 12.40 Total Reserves 1,943.32 1,690.32 1,523.66 1,436.88 1,382.52 681.45 518.91 316.38 297.30 142.17 Non-Current Liabilities 1,225.00 991.72 849.44 797.40 647.39 399.50 327.03 9.69 -19.27 87.85 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.00 54.03 Long Term Provisions 111.27 83.07 65.42 61.33 94.94 36.84 46.42 38.73 4.65 4.74 Current Liabilities 763.90 624.57 574.85 476.58 559.01 444.84 498.27 336.90 325.47 276.40 Trade Payables 306.95 298.96 253.03 260.14 246.23 148.09 234.15 162.67 128.79 110.66 Other Current Liabilities 330.25 241.24 241.81 189.35 148.29 111.39 122.35 61.27 34.81 13.85 Short Term Borrowings 0.00 0.00 0.00 0.00 142.68 135.24 105.05 104.40 154.36 137.54 Short Term Provisions 126.70 84.37 80.00 27.09 21.80 50.12 36.72 8.56 7.50 14.36 Total Liabilities 3,963.55 3,356.19 3,001.65 2,764.48 2,623.65 1,575.44 1,354.40 671.80 609.69 524.57 Net Block 1,594.53 1,296.37 1,241.83 1,137.96 798.73 517.30 419.46 89.70 83.47 80.57 Gross Block 2,558.48 2,051.45 1,861.94 1,615.62 1,114.11 740.94 689.67 160.49 143.30 135.49 Accumulated Depreciation 963.95 755.08 620.11 477.66 315.38 223.64 270.21 70.80 59.83 54.92 Non Current Assets 1,820.29 1,464.69 1,385.18 1,283.77 991.95 622.46 521.44 196.97 152.17 129.68 Capital Work in Progress 31.98 16.27 11.08 25.47 20.45 5.54 4.94 1.43 0.93 1.98 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 191.40 149.02 126.42 120.19 172.75 99.57 97.01 90.51 56.84 47.09 Other Non Current Assets 2.39 3.03 5.85 0.15 0.02 0.05 0.04 15.34 10.93 0.04 Current Assets 2,143.26 1,891.49 1,616.46 1,480.72 1,631.71 952.98 832.96 474.82 457.52 394.89 Current Investments 0.00 0.00 0.00 0.03 0.03 0.03 0.25 0.00 0.00 0.05 Inventories 1,381.69 1,345.10 1,340.23 1,144.09 914.98 749.96 643.55 394.07 363.25 334.56 Sundry Debtors 26.96 13.27 17.50 8.65 6.04 5.37 6.40 8.75 10.32 2.37 Cash & Bank 462.16 367.22 141.68 283.83 34.41 118.59 140.69 49.91 58.05 41.18 Other Current Assets 272.44 15.30 11.22 9.91 676.25 79.03 42.06 22.09 25.90 16.73 Short Term Loans & Adv. 256.01 150.61 105.82 34.20 644.51 71.46 28.88 12.11 18.41 16.04 Net Current Assets 1,379.36 1,266.92 1,041.62 1,004.14 1,072.70 508.14 334.69 137.92 132.04 118.49 Total Assets 3,963.55 3,356.18 3,001.64 2,764.49 2,623.66 1,575.44 1,354.40 671.79 609.69 524.57

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 61.98 46.68 8.37 11.40 -18.37 -6.24 2.89 PBT 83.17 51.17 6.94 7.59 5.58 -8.57 -24.36 Adjustment 29.46 31.43 31.09 3.39 0.65 8.22 31.25 Changes in Working Capital -29.11 -27.19 -27.34 2.24 -22.59 -6.17 -4.79 Cash after chg. in Working capital 83.53 55.41 10.69 13.22 -16.36 -6.52 2.10 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -21.55 -8.73 -2.32 -1.81 -2.01 0.28 0.79 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -22.03 -39.19 -24.42 31.72 -635.99 -14.77 -196.64 Net Fixed Assets -7.05 -14.93 -19.01 -111.19 -80.06 -17.76 Net Investments -2.41 -5.72 -5.35 -498.71 -9.95 -27.41 Others -12.57 -18.54 -0.06 641.62 -545.98 30.40 Cash from Financing Activity -4.79 -9.91 -5.97 -8.36 568.63 96.94 203.96 Net Cash Inflow / Outflow 35.15 -2.42 -22.03 34.77 -85.74 75.94 10.21 Opening Cash & Equivalents 11.30 13.72 35.70 0.94 86.68 10.74 0.53 Closing Cash & Equivalent 46.45 11.30 13.72 35.70 0.94 86.68 10.74

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 495.58 540.43 143.74 90.41 169.89 2.89 -6.59 PBT 275.33 183.29 73.44 47.16 117.94 95.10 29.36 Adjustment 393.63 353.76 330.62 272.76 187.88 182.28 155.41 Changes in Working Capital -99.29 48.61 -231.10 -215.58 -102.37 -245.77 -176.50 Cash after chg. in Working capital 569.67 585.65 172.96 104.34 203.45 31.61 8.27 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -74.09 -45.23 -29.22 -13.94 -33.56 -28.71 -14.86 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -127.72 -317.61 -82.80 429.44 -703.13 -34.55 -27.55 Net Fixed Assets -7.05 -14.93 -19.01 -111.19 -80.06 -17.76 Net Investments -2.41 -5.72 -5.35 -498.71 -9.95 -27.41 Others -118.26 -296.96 -58.44 1,039.34 -613.12 10.62 Cash from Financing Activity -255.50 -227.98 -198.10 -170.25 440.43 -5.63 89.83 Net Cash Inflow / Outflow 112.36 -5.16 -137.17 349.60 -92.81 -37.28 55.69 Opening Cash & Equivalents 86.05 91.21 228.38 -121.23 -28.42 8.87 -46.82 Closing Cash & Equivalent 198.41 86.05 91.21 228.38 -121.23 -28.42 8.87

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 108.96 101.43 96.82 93.11 92.32 2092.97 8220.31 7761.29 8182.90 8301.20 ROA 4.32% 2.97% 0.73% 0.45% 0.64% -1.78% -8.20% -4.77% -1.34% -1.65% ROE 4.95% 3.40% 0.83% 0.50% 0.71% -2.73% -14.80% -5.29% -1.44% -1.74% ROCE 7.16% 4.93% 1.32% 1.25% 1.01% -1.75% -8.30% -3.52% -1.00% -1.57% Fixed Asset Turnover 3.68 3.16 2.30 1.57 2.63 3.98 11.59 1.12 1.03 1.13 Receivable days 49.41 45.05 38.74 46.56 38.38 52.46 31.88 19.40 15.57 14.06 Inventory Days 8.76 7.60 7.46 8.37 10.16 22.76 12.43 17.35 16.63 16.21 Payable days 22.16 21.08 15.99 21.31 12.15 12.61 22.26 1130.61 1132.69 2107.52 Cash Conversion Cycle 36.01 31.57 30.21 33.62 36.39 62.61 22.06 -1093.85 -1100.48 -2077.26 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.06 0.00 Interest Cover 11.00 6.93 1.82 2.16 3.12 -14.16 -89.56 -2.67 -2.89 -14.12

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 163.87 143.22 129.47 122.44 117.89 3044.19 15034.43 ROA 6.00% 4.73% 2.27% 1.86% 4.51% 4.40% 0.18% ROE 11.93% 9.21% 4.36% 3.50% 9.07% 12.96% 0.59% ROCE 22.22% 18.22% 12.19% 9.56% 16.56% 21.69% 14.34% Fixed Asset Turnover 3.03 3.18 3.28 3.39 4.13 4.38 6.75 Receivable days 1.05 0.90 0.84 0.58 0.54 0.69 0.96 Inventory Days 71.25 78.76 79.52 81.27 79.28 81.18 65.97 Payable days 21.75 21.71 21.33 25.98 24.13 28.76 24.12 Cash Conversion Cycle 50.55 57.95 59.03 55.87 55.69 53.10 42.81 Total Debt/Equity 0.00 0.00 0.00 0.00 0.10 0.20 0.36 Interest Cover 3.00 2.54 1.65 1.48 2.42 2.41 1.63

Top Investors:

nippon life india trustee ltd-a/c nippon india pha

icici prudential pharma healthcare and diaganostic

franklin india flexi cap fund

sbi elss tax saver fund

kotak small cap fund

fidelity funds - india focus fund

kuwait investment authority fund 227

pravesa holding private limited

hdfc life insurance company limited

bajaj life insurance limited

Annual Reports:

News Update:

Medplus Health Serv. - Quarterly Results
22nd Jul 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback